Literature DB >> 7637541

An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes.

J C Leroux1, F De Jaeghere, B Anner, E Doelker, R Gurny.   

Abstract

We demonstrate here that polyethylene glycol (PEG) 6,000 protects biodegradable poly(D,L-lactic acid) nanoparticles (PLA NP) from extensive uptake by monocytes in plasma. These results are in agreement with those previously obtained with PEG 20,000 which reduced the uptake of PLA NP by human monocytes in phosphate buffered saline and plasma, and prolonged the NP circulation time in vivo. The coating efficiency of PEG 6,000 and 20,000 was substantially decreased in serum. The difference between the uptake of plain and coated NP clearly reappeared for PEG 20,000-coated NP in heat inactivated serum and in IgG-depleted serum. We suggest that typical plasma proteins, heat labile serum proteins (e.g. complement components) and IgG are involved in the opsonization of plain and coated PLA NP. Other proteins previously found to adsorb onto these NP, namely albumin and apolipoprotein E, did not appear to directly influence the uptake process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637541     DOI: 10.1016/0024-3205(95)00321-v

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  23 in total

1.  Pegylated nanocapsules produced by an organic solvent-free method: Evaluation of their stealth properties.

Authors:  Arnaud Béduneau; Patrick Saulnier; Nicolas Anton; François Hindré; Catherine Passirani; Holisoa Rajerison; Nicolas Noiret; Jean-Pierre Benoit
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

Review 2.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

3.  Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake.

Authors:  F De Jaeghere; E Allémann; J C Leroux; W Stevels; J Feijen; E Doelker; R Gurny
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

4.  Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA.

Authors:  Najung Kim; Dahai Jiang; Ashley M Jacobi; Kim A Lennox; Scott D Rose; Mark A Behlke; Aliasger K Salem
Journal:  Int J Pharm       Date:  2011-08-12       Impact factor: 5.875

5.  Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells.

Authors:  Leshuai W Zhang; Wolfgang Bäumer; Nancy A Monteiro-Riviere
Journal:  Nanomedicine (Lond)       Date:  2011-07       Impact factor: 5.307

6.  Questioning the Use of PEGylation for Drug Delivery.

Authors:  Johan J F Verhoef; Thomas J Anchordoquy
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

Review 7.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.

Authors:  Claudia Corbo; Roberto Molinaro; Alessandro Parodi; Naama E Toledano Furman; Francesco Salvatore; Ennio Tasciotti
Journal:  Nanomedicine (Lond)       Date:  2015-12-11       Impact factor: 5.307

Review 8.  Application of nanotechnologies for improved immune response against infectious diseases in the developing world.

Authors:  Michael Look; Arunima Bandyopadhyay; Jeremy S Blum; Tarek M Fahmy
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

Review 9.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Authors:  Parag Aggarwal; Jennifer B Hall; Christopher B McLeland; Marina A Dobrovolskaia; Scott E McNeil
Journal:  Adv Drug Deliv Rev       Date:  2009-04-17       Impact factor: 15.470

10.  Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate.

Authors:  Sofia Faraasen; János Vörös; Gábor Csúcs; Marcus Textor; Hans P Merkle; Elke Walter
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.